The latest issue of the Lung-MAP newsletter is out, and heading to sites.

A new sub-study just activated, and all the details are included. So are tips for sites, the latest accrual data, and an exciting screening update from Foundation Medicine. You can read the Spring 2021 issue here.

Other Recent Stories

European Urology
Jul 26, 2024
Tumors with alterations in any of three specific DNA damage-repair genes were more likely than other tumors to be eliminated by cisplatin-based chemotherapy.